CFO4Life Group’s Corpay CPAY Stock Holding History

CFO4Life Group’s Portfolio CPAY Stock Details CPAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,832	Closed	-$342K	–	132
2020 Q1	$342K	Sell	1,832 -215	-11%	-$59.3K	0.18%	77
2019 Q4	$589K	Sell	2,047 -51	-2%	-$15K	0.25%	58
2019 Q3	$602K	Sell	2,098 -287	-12%	-$83.4K	0.27%	53
2019 Q2	$670K	Buy	+2,385	New	+$624K	0.31%	48

Other funds holding CPAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

CFO4Life Group's CPAY Position: Q2 2020 in Review

CFO4Life Group sold out of Corpay (CPAY) in Q2 2020, closing a stake of 1,832 shares — an estimated $342K sold.

CFO4Life Group first reported a position in CPAY in Q2 2019 and held it in 4 quarters. The position peaked at $670K in Q2 2019. 531 funds tracked by Wall St. Rank hold CPAY as of Q2 2020.

CFO4Life Group reported no remaining Corpay position as of Q2 2020 after selling out during the quarter.
CFO4Life Group sold 1,832 Corpay shares in Q2 2020, an estimated $342K.
CFO4Life Group first reported a position in Corpay in Q2 2019 and held it in 4 quarters.
CFO4Life Group's Corpay position peaked at $670K in Q2 2019.
531 funds tracked by Wall St. Rank held Corpay as of Q2 2020.

Based on CFO4Life Group's 13F filing for Q2 2020, filed 15 Jul 2020.